# Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/considerations-for-long-term-clinical-neurodevelopmental-safety-studies-in-neonatal-product-development-guidance-for-industry/22231631-637d-4cb6-b141-338bfd78deaf

> FDA guidance document: Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development:  Guidance for Industry. Issue date: October 17, 2024. Get complete insights and analysis.

---

## Details

- Title: Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: devices
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2024-10-17
- Last Changed: 2024-10-17
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2022-D-0112">FDA-2022-D-0112</a>

## Related Documents

- [Atopic Dermatitis: Timing of Pediatric Studies During Development of Systemic Drugs](https://www.globalkeysolutions.net/guidances/guidance-document/atopic-dermatitis-timing-of-pediatric-studies-during-development-of-systemic-drugs/287c413c-cc5e-49ee-af83-9d7183bc4f4d)
- [General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/general-clinical-pharmacology-considerations-for-neonatal-studies-for-drugs-and-biological-products-guidance-for-industry/0c57731e-55bc-4962-a619-54444aa22335)
- [Use of Electronic Health Record Data in Clinical Investigations Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/use-of-electronic-health-record-data-in-clinical-investigations-guidance-for-industry/165621f1-dbb5-4b0f-a30a-c5d0ea2e7d02)